One of the suggestions we get regularly here at Retraction Watch is something along the lines of “This researcher publishes too much. You should look into that.” But how much is too much? The phenomenon was the subject of a 2015 paper. It’s also the subject of a new article in Nature by John Ioannidis, … Continue reading When it comes to authorship, how prolific is too prolific?
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured the retraction of a Nature paper over the objections of … Continue reading Weekend reads: Kim Kardashian loses an authorship; legal threats follow misconduct allegations; faked job offer leads to prosecution
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction featured a paper by Kim Kardashian, four retractions for an author who … Continue reading Weekend reads: Ghostwritten thesis apps; discriminatory authorship rules; group up to 14 retractions
For a host of reasons, a journal has retracted a paper co-authored by a researcher who reportedly once faced charges of practicing medicine without proper qualifications. According to the retraction notice for “Psorinum Therapy in Treating Stomach, Gall Bladder, Pancreatic, and Liver Cancers: A Prospective Clinical Study,” published Dec. 8, 2010 in Evidence-Based Complementary and … Continue reading Ethics, authorship concerns sink homeopathy paper by researchers arrested last year
We’ve been having some technical issues with the site, which may have kept some readers from accessing our content this week. We think we’ve figured out what was wrong, and fixed it, but in the meantime here’s what we were up to this week, in case you missed it:
A journal has retracted a warning posted to a paper involved in an authorship dispute, after the issue was resolved in a court case. In an editorial published Jan. 10, editors at the journal Molecules wrote that they were removing the expression of concern for “Helleborus purpurascens—Amino Acid and Peptide Analysis Linked to the Chemical … Continue reading Journal retracts note of concern after court settles authorship dispute
A journal has retracted a 2014 paper because of an authorship dispute that became the subject of litigation. Last year, the Allegheny Health Network in Pittsburgh requested the paper be retracted to resolve the dispute. The Journal of Applied Biomaterials & Functional Materials retracted the paper in October. According to the retraction notice, the principal … Continue reading “The most terrible experience of my life:” Authorship dispute leads to lawsuit
The week at Retraction Watch featured the retraction of a paper that had been called “anti-vaccine pseudoscience,” a retraction following threats of violence against an editor, and an editorial board member’s resignation over how a journal handled a case of plagiarism. Here’s what was happening elsewhere:
Got $300? Then you can be added as an author to a paper — even if you had no role in the research. That’s right — some journals are willing to add authors to papers they didn’t write, often for a fee. This realization comes from one of the many sting experiments we’ve witnessed over … Continue reading Authorship for sale: Some journals willing to add authors to papers they didn’t write
The week at Retraction Watch featured the revocation of a PhD, a questionable way to boost university rankings, and a look at what editors should do when a researcher known to have committed misconduct submits a new manuscript. Here’s what was happening elsewhere: